Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Antibiotic May Stave Off MS

Study finds minocycline fights disease in rats

By Robin Foster
HealthScoutNews Reporter


Related Encyclopedia
 border=
Abscess
Acoustic Neurinoma
Actinomycosis
Acute Myeloid Leukemia (Adult)
More...

Related Healthscout Videos
 border=
At-Home Stroke Rehab
Fixing Babies' Heads
Attacking Implant Infections
How Can a Child ADHD Patient Get More Organized?
More...

Related Drug Information
 border=
Abilify
Adderal XR
Augmentin
Bactroban Cream
More...

Related News Articles
 border=
Immune System Research Sees Many Similarities Among People
Mental 'Exercise' May Only Hide Signs of Alzheimer's
Health Tip: Signs That People With Dementia Shouldn't Drive
Genetic Studies Find Clues to 'Lou Gehrig's Disease' Risk
More...

FRIDAY, Dec. 21 (HealthScoutNews) -- Multiple sclerosis (MS), a crippling disease of the central nervous system, could one day be treated with a common antibiotic, a new study suggests.

Researchers at the University of Wisconsin, in collaboration with German scientists, found that minocycline helped rats fight off a disease that's the animal equivalent of chronic MS in humans. The drug could decrease the severity of MS symptoms or even prevent relapses, they say. The findings appear in today's issue of the Annals of Neurology.

Text Continues Below



"It would either block the disease or lessen the severity of the disease. It protects the central nervous system," says senior author Ian Duncan.

One expert finds the results encouraging and exciting, but adds a caveat.

"I think we always have to temper our enthusiasm with a certain amount of caution until it's been tested on humans," says Nicholas G. LaRocca, director of health-care delivery and policy research at the National Multiple Sclerosis Society. Some treatments that have worked in the rat model of MS have been successful in humans, but many have not, he says.

Duncan acknowledges that, but he says the rat model is the best available model for MS, and it's used to test most MS drugs before human trials. And he says a human clinical trial already has been scheduled next year at the University of Calgary.

"We need to do more work to nail this down" to determine more specifically exactly how minocycline works on the nervous system, Duncan says.

MS, which affects more than 300,000 Americans, is characterized by inflammation and the loss of the myelin sheaths that protect the body's nerve fibers. Symptoms include numbness and possible paralysis, as the brain's ability to send signals to the rest of the body is weakened by the progressive destruction of myelin. The disease has no known cause or cure, and the triggers for relapses remain unclear. As the disease moves into its final stages, the sheaths are damaged and nerve fibers are destroyed.

Page:  1 | 2 | Next >>

Copyright © 2001 ScoutNews, LLC. All rights reserved.
Last updated 12/21/2001

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





SOURCES: Interviews with Ian Duncan, Ph.D., BVMS, professor, neurology, department of medical sciences, School of Veterinary Medicine, University of Wisconsin, Madison; Nicholas G. LaRocca, director, health-care delivery and policy research, National Multiple Sclerosis Society, New York City; Dec. 21, 2001, Annals of Neurology


About The HealthScout Network Contact Us
Copyright © 2001-2010. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy